<DOC>
	<DOCNO>NCT00311740</DOCNO>
	<brief_summary>The purpose study compare effect fix combination valsartan+hydrochlorothiazide ( HCTZ ) blood pressure reduction valsartan HCTZ alone whether combination treatment safe well tolerate . The study aim establish dose response relationship monotherapies combination . This study conduct Japan .</brief_summary>
	<brief_title>A Study VAH631 Patients With Essential Hypertension ( Factorial Study )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Essential hypertension measure mercury sphygmomanometer Outpatients Secondary hypertension suspect secondary hypertension . A history malignant hypertension Severe hypertension Significant heart , renal , hepatic disease significant cerebrovascular disorder Gout Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hypertension ,</keyword>
	<keyword>Valsartan ,</keyword>
	<keyword>Hydrochlorothiazide</keyword>
</DOC>